JOHNSON & JOHNSON — Director's Dealing 2024

Feb 15, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2024-02-12

Reporting Person: Taubert Jennifer L (EVP, WWC. Innovative Medicine)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-12	Common Stock	M	22433.0000	$0.0000	Acquired	163849.0010	Direct
2024-02-12	Common Stock	M	3769.0000	$0.0000	Acquired	167618.0010	Direct
2024-02-12	Common Stock	F	13403.0000	$157.4000	Disposed	154215.0010	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-12	Performance Share Units	$	M	22433.0000	Disposed		Common Stock (22433.0000)	Direct

Footnotes

F1: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024.

F2: Shares earned due to performance factor of 116.8% upon certification of performance results by the Board.

F3: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.